Disc Medicine (IRON) Net Cash Flow (2020 - 2026)

Disc Medicine (IRON) has 7 years of Net Cash Flow data on file, last reported at -$2.2 million in Q1 2026.

• On a quarterly basis, Net Cash Flow rose 96.8% year-over-year to -$2.2 million in Q1 2026; TTM through Mar 2026 was -$33.8 million, a 84.65% increase from a year earlier, with the FY2025 full-year figure at -$101.3 million, up 39.69% from the prior year.
• Net Cash Flow for Q1 2026 stood at -$2.2 million, up from -$49.5 million in the prior quarter.
• Over the last five years, Net Cash Flow for IRON reached as high as $141.1 million in Q2 2023 and fell as low as -$88.0 million in Q3 2024.
• Historically, Net Cash Flow has averaged $55411.8 across 5 years, with a median of -$9.1 million in 2022.
• Across the five-year window, Net Cash Flow surged 1646.0% in 2023 and tumbled 24413.37% in 2025, its largest moves.
• Year by year, Net Cash Flow stood at $139.1 million in 2022, then sank by 107.22% to -$10.0 million in 2023, then soared by 97.99% to -$202000.0 in 2024, then tumbled by 24413.37% to -$49.5 million in 2025, then surged by 95.49% to -$2.2 million in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were -$2.2 million in Q1 2026, -$49.5 million in Q4 2025, and $13.3 million in Q3 2025.